What happened
Ilyang Pharmaceutical updated the disclosed terms of an acquisition of Ilyang Pharmaceutical (Jilin) Co., Ltd., now worth US$11.4M.
For context, this deal is worth about 3.9% of the company's own total assets.
| Target | Ilyang Pharmaceutical (Jilin) Co., Ltd. |
|---|---|
| Deal value | US$11.4M |
| vs. company assets | 3.9% |
| Filed | 2026-06-30, [Amended] Decision to acquire shares/equity in another company |
| Source | DART rcept 20260630800832 → open original filing |
Versions of this filing
- 2026-05-14Original
- 2026-06-30Amendment 1 (this page)
Source: DART. Information only, not investment advice.